• 3696 Citations
  • 20 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giulia Valeria Bianchi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
exemestane Medicine & Life Sciences
letrozole Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Extravehicular Activity Medicine & Life Sciences
Safety Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

  • 3696 Citations
  • 20 h-Index
  • 55 Article
  • 2 Chapter
  • 1 Comment/debate
  • 1 Review article

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: Results of the PerELISA neoadjuvant study

Guarneri, V., Dieci, M. V., Bisagni, G., Frassoldati, A., Bianchi, G. V., De Salvo, G. L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C. A., Moretti, G., Griguolo, G., Vicini, R., Prat, A. & Conte, P. F., Jun 1 2019, In : Annals of Oncology. 30, 6, p. 921-926 6 p., mdz055.

Research output: Contribution to journalArticle

Open Access
Breast Neoplasms
Drug Therapy

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2019, In : Breast Care.

Research output: Contribution to journalArticle

Extravehicular Activity
Breast Neoplasms
Aromatase Inhibitors
Open Access
Triple Negative Breast Neoplasms

Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives

Vernieri, C., Milano, M., Brambilla, M., Mennitto, A., Maggi, C., Cona, M. S., Prisciandaro, M., Fabbroni, C., Celio, L., Mariani, G., Bianchi, G. V., Capri, G. & de Braud, F., Jul 2019, In : Critical Reviews in Oncology/Hematology. 139, p. 53-66 14 p.

Research output: Contribution to journalReview article

Therapeutic Human Experimentation
Breast Neoplasms
Standard of Care
Treatment Failure
Pharmaceutical Preparations

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Vernieri, C., Prisciandaro, M., Milano, M., Cona, M. S., Maggi, C., Brambilla, M., Mennitto, A., Fabbroni, C., Farè, E., Cresta, S., Celio, L., Mariani, G., Bianchi, G., Capri, G. & de Braud, F., Apr 2019, In : Clinical Breast Cancer. 19, 2, p. e306-e318

Research output: Contribution to journalArticle

Breast Neoplasms
Disease-Free Survival